Nothing to Sneeze At! Global Pharma-Bio Sector Wraps Up $4.74 Billion in Construction Projects in 2Q17
Attachment: Pharma-Biotech Completions 2Q17
SUGAR LAND--June 14, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--At the end of the second quarter of 2017, the global Pharmaceutical & Biotech Industry will have wrapped up construction on nearly $5 billion worth of reported capital and maintenance investments. Spread over 242 individual projects, construction should be complete between April 1 and June 30.
Within this article: Details on some of the major project completions from the second quarter, including those from top companies such as CSL Behring LLC, Takeda Pharma Vertrieb GmbH & Company and Elanco Animal Health.
